Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Eric Schaefer (NPI 1558325118)

Field	Value
Entity Type	Individual
Organization	Eric Schaefer
Address	808 S 52nd St
City	Rogers
State	AR
ZIP	72758
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	April 12, 2006

Payer Source	Total Paid
Medicare	$3.6M
Medicaid	$0

Key Findings

ERIC SCHAEFER is a hematology & oncology physician whose public-payer footprint is concentrated in Medicare with Total Medicare revenue of $3.6M and no Medicaid billing on file; this makes the provider effectively single-payer within public programs and exposes his public-revenue base to Medicare policy and beneficiary trends. The provider’s NPI was enumerated 2006-04-12 (~20 years ago), indicating a long-tenured Medicare billing history that could support established referral relationships and steady case volume.

Revenue is highly concentrated in a small set of oncology-related services: J9271 generated $1.2M (34.2% of Medicare revenue), J9299 generated $564.5K (16.8%), and 78815 generated $425.9K (12.7%), and the precomputed top-3 codes account for 63.7% of this provider's total Medicare revenue. This concentration shows that a few high-cost infusions and advanced imaging studies drive the majority of billed Medicare dollars.

The code mix is consistent with an infusion-based oncology practice that uses immune checkpoint inhibitors and advanced imaging: high-revenue administration codes J9271 and J9299 (pembrolizumab and nivolumab) plus chemotherapy infusion code 96413 and PET/CT 78815 point to routine administration of systemic cancer therapy combined with PET/CT imaging for staging or treatment assessment. Additional supportive and specialty agents such as J0897 (denosumab), J1561 (immune globulin), and Q5115 (rituximab-abbs) further indicate integrated infusion and supportive-care services common in oncology practices.

Competitive standing for high-cost immunotherapy infusions is solid but not dominant nationally: J9271 (28.8K claims, $1.2M revenue) ranks #139 of 1841 providers nationally (92th percentile; typical, unremarkable volume) and J9299 (23.5K claims, $564.5K revenue) ranks #120 of 505 providers nationally (76th percentile; typical, unremarkable volume). Those ranks suggest the provider bills substantial absolute dollars for these drugs but does so at volumes characterized as typical relative to national peers in the specialty.

Imaging and high-complexity outpatient visit volumes stand out versus national peers: 78815 (420 claims, $425.9K revenue) ranks #323 of 6566 providers nationally (95th percentile; notably above typical national volume), while CT abdomen/pelvis 74178 (484 claims, $87.1K revenue) ranks #12 of 11397 (100th percentile; extreme outlier) and high-level E/M 99215 (780 claims, $98.3K revenue) ranks #579 of 145531 (100th percentile; extreme outlier). These percentile signals together suggest unusually high reliance on advanced imaging and high-complexity office visits compared with the broader national provider population, which may reflect either a high-acuity case mix or strong referral pathways to imaging resources.

The provider shows adoption of biosimilars and supportive biologic therapies alongside branded immunotherapies, with Q5115 (rituximab-abbs) at $111.5K revenue and Q5118 (bevacizumab-bvzr) at $45.8K revenue, plus Q5108 (pegfilgrastim-jmdb) $32K and Q5106 (epoetin alfa-epbx) $18.9K. Presence of both branded agents (J9271, J9299) and biosimilars indicates a therapeutic mix that balances high-cost oncology agents with biosimilar substitution and supportive-care injectables typical of infusion oncology operations.

Beyond the top immunotherapy codes, several routine oncology and laboratory services appear at relatively high percentiles versus national peers — for example, chemotherapy administration 96413 (758 claims, $66.7K revenue) ranks #207 of 7514 providers nationally (97th percentile; notably above typical national volume) and common lab panels 80053 (2.3K claims, $23.4K revenue) rank #541 of 26416 (98th percentile; typical, unremarkable volume). These patterns reinforce a practice profile that combines frequent infusion visits with substantial ancillary testing and monitoring.

Because there is no Medicaid billing on file, this profile should be interpreted as reflecting Medicare-dominant public-payer exposure rather than a mixed public-payer strategy; analysts should consider that changes in Medicare reimbursement for high-cost drugs, imaging, or E/M billing could materially affect reported public revenue while Medicaid-related revenue and risk are not observable in the public billing record.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

124 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	28,800	$40	$1.2M
J9299	Injection, nivolumab, 1 mg	23,520	$20	$564.5K
78815	PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.…	420	$1,010	$425.9K
J0897	Injection, denosumab, 1 mg	9,060	$20	$172.1K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	4,370	$40	$166.1K
Q5115	Injection, rituximab-abbs, biosimilar, (truxima), 10 mg	3,280	$30	$111.5K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	780	$130	$98.3K
74178	The provider performs computed tomography of the abdomen and pelvis without contrast material in one or both body regions followed by contrast material in one or both body regions and additional…	480	$180	$87.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	790	$90	$68.6K
A9596	Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie	70	$1,030	$68.2K

Showing 1–10 of 124

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 124 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Eric Schaefer — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

124 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	8	40	20,700	$40	$896.3K
J9299	8	30	15,660	$20	$432.9K
J1561	10	10	5,930	$40	$216.4K
Q5115	8	20	2,800	$30	$95.9K
J0897	28	160	2,580	$20	$89.7K
A9596	10	10	80	$850	$87.3K
78815	6	100	90	$550	$83.7K
Q5118	7	10	2,110	$20	$64.3K
J0885	20	40	4,070	$10	$38K
96413	14	80	380	$90	$36.6K

Showing 1–10 of 124

Related Providers

Other providers that share a Tax Identification Number (TIN) with Eric Schaefer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
North Shore Hematology Oncology Associates PC	NY	Specialist	$0	$61.9M
Highlands Oncology Group PA	AR	Hematology & Oncology Physician	$0	$5.7M
Matthew Lockwood	AR	Hematology & Oncology Physician	$4.2M	$0
Patrick Travis	AR	Hematology & Oncology Physician	$3.3M	$0
K'anne Arthur	AR	Hematology & Oncology Physician	$3.2M	$0
Gregory Oakhill	AR	Hematology & Oncology Physician	$2.8M	$0
Stephan Rosenfeld	AR	Hematology & Oncology Physician	$2.3M	$0
J Beck	AR	Hematology & Oncology Physician	$2.2M	$0
Dmitriy Zak	AR	Hematology & Oncology Physician	$2.2M	$0
Mitchell Ross	AR	Hematology & Oncology Physician	$2.2M	$0

Nearby Providers

Other providers in the same ZIP code as Eric Schaefer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mercy Hospital Rogers	AR	General Acute Care Hospital	$0	$14.2M
Mercy Health Northwest Arkansas Communities	AR	Multi-Specialty Clinic/Center	$0	$8.4M
St. Francis House Nwa, Inc.	AR	Dental Clinic/Center	$0	$2.9M
Daniel Bradford	AR	Hematology & Oncology Physician	$2.8M	$0
Northwest Arkansas Pediatric Dental Center	AR	Pediatric Dentistry	$0	$2.5M
Brian T Hyatt Md LLC	AR	Psychiatry Physician	$0	$2.1M
Mercy Hospital Rogers	AR	Home Health Agency	$0	$1.8M
Harvey Pediatrics. PLLC	AR	Pediatrics Physician	$0	$1.8M
Precision Surgical Center Of Northwest Arkansas, LLC	AR	Ambulatory Surgical Clinic/Center	$1.8M	$0
Michael Garone	AR	Dermatology Physician	$1.2M	$0

Eric Schaefer — Billing Profile & Reimbursement Data

Sign up for Eric Schaefer — Billing Profile & Reimbursement Data policy alerts

Eric Schaefer — Billing Profile & Reimbursement Data

Sign up for Eric Schaefer — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References